Lipid Management
Lipid Management
Advertisement
Jordana JampelAtherosclerotic Disease | April 17, 2025
This structural discovery is a step toward the development of next-generation therapies to modulate LDL.
Read More
Rob DillardLipid Management | April 17, 2025
Patient outreach with bulk ordering may result in higher lipid screening uptake than usual care.
Rob DillardLipid Management | April 17, 2025
A study found a comparable reduction in LDL-C with statins and bempedoic acid in patients with and without ASCVD.
Rob DillardLipid Management | April 17, 2025
Researchers have developed a machine learning model which can identify people who are likely to have elevated Lp(a).
Rob DillardLipid Management | April 17, 2025
Bempedoic acid treatment is similarly effective at lowering low-density lipoprotein cholesterol compared with statins.
CardioNerdsCardiology | April 17, 2025
The CardioNerds and colleagues address the topic of familial hypercholesterolemia.
Rob DillardLipid Management | April 17, 2025
Women with cardiovascular disease are treated with cholesterol-lowering therapies less often than men.
Rob DillardLipid Management | April 17, 2025
Researchers assessed the impact of 4 diet programs—vegan, Mediterranean, Paleolithic, and DASH—on cardiovascular risk.
Rob DillardLipid Management | April 17, 2025
US veterans have a disproportionately high risk of atherosclerotic cardiovascular disease and a low adherence to LLT.
Rob DillardACC 2024 | April 17, 2025
Older firefighters may have more thrombotic risk factors that contribute to a higher risk of coronary heart disease.
Rob DillardLipid Management | April 17, 2025
Distinct variations of coronary artery calcium-derived coronary artery heart disease exist among retired NFL players.
Rob DillardACC 2024 | April 17, 2025
A remote, algorithm-based program is effective at helping patients achieve optimal LDL-C levels for at least 12 months.
Cynthia Miller, MDLipid Management | April 17, 2025
Cynthia Miller, MD, MPH, FACP, discusses why early Lp(a) screening may help prevent cardiovascular disease.
Rob DillardAHA 2023 | April 17, 2025
Elevated lipoprotein(a) increases the risk of major adverse cardiovascular events independent of ASCVD risk scores.
Alaa DiabCardioNerds | April 17, 2025
The following article was written by Dr. Alaa Diab as a CardioNerds Conference Scholar for ...
Rob DillardLipid Management | April 17, 2025
High cholesterol is a major risk factor for heart disease, which affects nearly 94 million Americans and is the leading ...
Rob DillardLipid Management | April 17, 2025
DocWire News recently spoke Dr. Suzanne Steinbaum, cardiologist, published author, and womens’ wellness advocate. Dr. ...
Rob DillardAtherosclerotic Disease | April 17, 2025
A literature review uncovered a significant scarcity of cost-of-illness studies on the economic impact of familial ...
DocWire News EditorsLipid Management | April 17, 2025
Elevated levels of the lipid ceramide, which increase mortality risk for cardiovascular disease, were held in check by ...
DocWire News EditorsLipid Management | April 17, 2025
A new analysis suggests that omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) failed to ...
Advertisement
Advertisement